---
company: Adient plc
ticker: ADNT
form: 8-K
filed: 2026-11-04
accepted: 2026-11-04T11:49:32+00:00
accession: 0001670541-26-000114
source: https://www.sec.gov/Archives/edgar/data/1670541/000167054126000114/
---

# Adient (ADNT) Q3 2026 earnings

## Header

- Company: Adient plc
- Reported: 2026-11-04 06:49 BMO ET
- Source: 8-K only — accession 0001670541-26-000114, Item 2.02 + Exhibit 99.1
- Verdict: Adjusted EBITDA margin held steady at 6.1% while revenue declined 0.1% YoY, but GAAP net income swung to a loss driven by restructuring and pension mark-to-market losses.

## Headline numbers

| Metric | Actual | YoY | QoQ | 8-K location |
|---|---|---:|---:|---|
| Revenue | $3.73B | -0.1% | -5.0% | Ex. 99.1, income statement |
| EPS (GAAP) | -$0.62 | -382% | -94% | Ex. 99.1, income statement |
| EPS (adjusted) | $0.52 | 0% | -84% | Ex. 99.1, income statement |
| Net income | -$20M | -153% | -150% | Ex. 99.1, income statement |
| Adj. EBITDA | $229M | 1% | -2% | Ex. 99.1, income statement |
| Adj. EBITDA margin | 6.1% | 0 pp | -0.4 pp | Ex. 99.1, income statement |

## Revenue breakdown

| Segment | Actual | YoY | Share of revenue | Note |
|---|---:|---:|---:|---|
| Americas | $1,543M | +2% | 41% | — |
| EMEA | $1,418M | -3% | 38% | — |
| Asia Pacific/China | $769M | -4% | 21% | — |

## Margins and costs

- Gross margin: 6.7% (prior 6.7%, change 0.0 pp)
- Operating expenses: $151M (+19% YoY)
- One-offs in the quarter: Restructuring and impairment charges $74M; Pension mark-to-market and settlement loss $16M; Gain on disposal transactions $0M; Fees paid on Term Loan B modifications $0M; Premium paid on repurchase of debt $0M; Write off of deferred financing costs upon repurchase of debt $0M
- Effective tax rate: 900% (prior-year 41%, year-to-date 64%)
- Non-GAAP bridge: Adds back restructuring and impairment costs, purchase accounting amortization, restructuring related activities, other items, depreciation, and equity-based compensation.

## KPIs

| Metric | Actual | Prior quarter | Prior year | Change |
|---|---:|---:|---:|---:|
| Adjusted EBITDA | $229M | $225M | $226M | +2% |
| Free cash flow | $121M | $137M | $129M | -12% |
| Net debt | $4,799M | $4,819M | $4,822M | -0% |

## Guidance

not stated in the 8-K

## What drove it

- Revenue story: Americas revenue grew 2% YoY, while EMEA and Asia Pacific declined 3% and 4% respectively.
- EPS story: Adjusted EPS fell due to a $102M increase in EBIT adjustments (primarily restructuring and impairment charges) and a $16M pension mark-to-market loss.
- One-off check: Restructuring and impairment charges $74M (vs $11M YoY) and pension mark-to-market & settlement loss $16M.

## The good

- Adjusted EBITDA margin held steady at 6.1% YoY
- Americas revenue grew 2% YoY

## The bad

- GAAP net income swung to a loss of $20M
- Adjusted EPS declined 84% QoQ to $0.52
- SG&A expenses increased 19% YoY

## The ugly

- Net income attributable to Adient swung to a loss of $47M driven by restructuring and pension losses

## Open questions

- The release does not provide specific guidance for the next quarter or year.
- The release does not explain the specific drivers for the decline in EMEA and Asia Pacific revenue.

## Full release

### Adient (ADNT) earnings release, November 4, 2026

Adient plc (ADNT) · Form 8-K, Item 2.02 · Filed 2026-11-04 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1670541/000167054126000114/)

Appendix

Page 1

Adient plc

Condensed Consolidated Statements of Income (Loss)

(Unaudited)

Appendix

Page 2

Adient plc

Condensed Consolidated Statements of Financial Position

(Unaudited)

Appendix

Page 3

Adient plc

Condensed Consolidated Statements of Cash Flows

(Unaudited)

Appendix

Page 4

Footnotes

1. Segment Results

Adient manages its business on a geographic basis and operates in the following three reportable segments for financial reporting purposes: 1) Americas, which is inclusive of North America and South America; 2) Europe, the Middle East and Africa ("EMEA") and 3) Asia Pacific/China ("Asia").

Adient evaluates the performance of its reportable segments using an adjusted EBITDA metric defined as income (loss) before income taxes and noncontrolling interests, excluding net financing charges, restructuring and impairment costs, restructuring related-costs, net mark-to-market adjustments on pension and postretirement plans, transaction gains/losses, purchase accounting amortization, depreciation, stock-based compensation and other non-recurring items ("Adjusted EBITDA"). Also, certain corporate-related costs are not allocated to the segments. The reportable segments are consistent with how management views the markets served by Adient and reflect the financial information that is reviewed by its chief operating decision maker.

Financial information relating to Adient's reportable segments is as follows:

Appendix

Page 5

Refer to the Footnote Addendum for footnote explanations.

2. Earnings Per Share

The following table reconciles the numerators and denominators used to calculate basic and diluted earnings (loss) per share:

Appendix

Page 6

3. Non-GAAP Measures

Adjusted EBIT, adjusted EBIT margin, adjusted EBITDA, adjusted EBITDA margin, adjusted net income attributable to Adient, adjusted effective tax rate, adjusted earnings per share, adjusted equity income, adjusted interest expense, free cash flow, net debt, and net leverage ratio as well as other measures presented on an adjusted basis are not recognized terms under U.S. GAAP and do not purport to be alternatives to the most comparable U.S. GAAP amounts. Since all companies do not use identical calculations, our definition and presentation of these measures may not be comparable to similarly titled measures reported by other companies. Management uses the identified non-GAAP measures to evaluate the operating performance of the Company and its business segments and to forecast future periods. Management believes these non-GAAP measures assist investors and other interested parties in evaluating Adient's on-going operations and provide important supplemental information to management and investors regarding financial and business trends relating to Adient's financial condition and results of operations. Investors should not consider these non-GAAP measures as alternatives to the related GAAP measures. Reconciliations of non-GAAP measures to their closest U.S. GAAP equivalent are presented in the corresponding tables that follow the definitions below. Reconciliations of non-GAAP measures related to guidance for any future period have not been provided due to the unreasonable efforts it would take to provide such reconciliations.

Appendix

Page 7

Reconciliations of non-GAAP measures to their closest US GAAP equivalent:

(a) & (b) Adjusted EBIT and Adjusted EBITDA

The following table reconciles net income (loss) to EBIT, adjusted EBIT and adjusted EBITDA:

Refer to the Footnote Addendum for footnote explanations.

Appendix

Page 8

(c) Adjusted net income attributable to Adient

The following table reconciles net income (loss) attributable to Adient to adjusted net income attributable to Adient:

Refer to the Footnote Addendum for footnote explanations.

(d) Adjusted income tax expense and effective tax rate

The following tables reconcile income (loss) before income taxes to adjusted income before income taxes, income tax expense (benefit) to adjusted income tax expense (benefit) and presents the related effective tax rate and adjusted effective tax rate:

Appendix

Page 9

(e) Adjusted diluted earnings per share

The following table shows the calculation of diluted earnings per share on an adjusted basis:

Appendix

Page 10

The following table reconciles diluted earnings (loss) per share as reported to adjusted diluted earnings per share (see table (c) for corresponding dollar amounts):

(f) Adjusted equity income

The following table reconciles equity income to adjusted equity income:

(g) Adjusted interest expense

The following table reconciles net financing charges to adjusted net financing charges:

Appendix

Page 11

(h) Free cash flow

The following table reconciles cash from operating activities to free cash flow:

** Free cash flows for the twelve months ended September 30, 2026 and 2025 exclude dividends paid to noncontrolling interests of $92 million and $90 million, respectively.

The following table reconciles adjusted EBITDA to free cash flow:

Appendix

Page 12

(i) & (j) Net debt and net leverage ratio

The following table presents calculations of net debt and net leverage ratio:

Appendix

Page 13

Footnote Addendum

(1) Corporate-related costs not allocated to the segments include executive office, communications, corporate development, legal and corporate finance.

(2) Reflects restructuring charges for costs that are probable and reasonably estimable and one-time asset impairments, including a $333 million goodwill impairment and an $8 million impairment of the Adient Aerospace joint venture recorded during the twelve months ended September 30, 2025.

(3) Reflects amortization of intangible assets including those related to partially owned affiliates recorded within equity income.

(4) Reflects restructuring-related charges for costs that are recorded as incurred or as earned and other non-recurring impacts that are directly attributable to restructuring activities:... (truncated)ecorded during the twelve months ended September 30, 2025.

(6) Other items include:

(7) Reflects the impact of adjustments, primarily purchase accounting amortization on noncontrolling interests.

#### Financial statements

##### Income Statement (Three Months Ended September 30, — (Unaudited) (in millions, except per share data))

| | Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Twelve Months Ended September 30, – 2026 | Twelve Months Ended September 30, – 2025 |
|---|---:|---:|---:|---:|
| Net sales | 3,730 | 3,688 | 15,168 | 14,535 |
| Cost of sales | 3,481 | 3,441 | 14,210 | 13,574 |
| Gross profit | 249 | 247 | 958 | 961 |
| Selling, general and administrative expenses | 151 | 124 | 555 | 522 |
| Restructuring and impairment costs | 74 | 11 | 108 | 392 |
| Equity income | 20 | 8 | 80 | 68 |
| Earnings before interest and income taxes | 44 | 120 | 375 | 115 |
| Net financing charges | 62 | 49 | 206 | 193 |
| Other pension expense (income) | -16 | 7 | -11 | 10 |
| Income (loss) before income taxes | -2 | 64 | 180 | -88 |
| Income tax expense | 18 | 26 | 115 | 103 |
| Net income (loss) | -20 | 38 | 65 | -191 |
| Income attributable to noncontrolling interests | 27 | 20 | 82 | 90 |
| Net income (loss) attributable to Adient | -47 | 18 | -17 | -281 |
| Diluted earnings (loss) per share | -0.62 | 0.22 | -0.22 | -3.39 |
| Shares outstanding at period end | 74.8 | 79.2 | 74.8 | 79.2 |
| Diluted weighted average shares | 76.1 | 81.3 | 77.8 | 83 |

##### Income Statement (Three Months Ended September 30, — The following table reconciles net income (loss) to EBIT, adjusted EBIT and adjusted EBITDA: (in millions))

| | Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Twelve Months Ended September 30, – 2026 | Twelve Months Ended September 30, – 2025 |
|---|---:|---:|---:|---:|
| Net income (loss) | -20 | 38 | 65 | -191 |
| Net financing charges | 62 | 49 | 206 | 193 |
| Other pension expense (income) | -16 | 7 | -11 | 10 |
| Income tax expense | 18 | 26 | 115 | 103 |
| Earnings before interest and income taxes (EBIT) | 44 | 120 | 375 | 115 |
| **EBIT adjustments:** | | | | |
| Restructuring and impairment charges (2) | 74 | 11 | 108 | 392 |
| Purchase accounting amortization (3) | 12 | 12 | 47 | 47 |
| Restructuring related activities (4) | 9 | -2 | 30 | 11 |
| Gain on disposal transactions (5) |  |  |  | -4 |
| Other items (6) | 7 | 1 | 4 | 9 |
| EBIT adjustments total | 102 | 22 | 189 | 455 |
| Adjusted EBIT | 146 | 142 | 564 | 570 |
| **EBITDA adjustments:** | | | | |
| Depreciation | 75 | 72 | 286 | 279 |
| Equity based compensation | 8 | 12 | 34 | 32 |
| Adjusted EBITDA | 229 | 226 | 884 | 881 |
| Net sales | 3,730 | 3,688 | 15,168 | 14,535 |
| Net income (loss) as % of net sales | -0.5 | 1 | 0.4 | -1.3 |
| EBIT as % of net sales | 1.2 | 3.3 | 2.5 | 0.8 |
| Adjusted EBIT as % of net sales | 3.9 | 3.9 | 3.7 | 3.9 |
| Adjusted EBITDA as % of net sales | 6.1 | 6.1 | 5.8 | 6.1 |

##### Income Statement (Three Months Ended September 30, — The following table shows the calculation of diluted earnings per share on an adjusted basis: (in millions, except per share data))

| | Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Twelve Months Ended September 30, – 2026 | Twelve Months Ended September 30, – 2025 |
|---|---:|---:|---:|---:|
| Adjusted net income attributable to Adient - see table (c) | 40 | 42 | 147 | 161 |
| **Denominator:** | | | | |
| Basic weighted average shares outstanding | 76.1 | 80.3 | 77.8 | 83 |
| **Effect of dilutive securities:** | | | | |
| Unvested restricted stock and unvested performance share awards | 1.3 | 1 | 1 | 0.4 |
| Diluted weighted average shares outstanding | 77.4 | 81.3 | 78.8 | 83.4 |
| Adjusted diluted earnings per share | 0.52 | 0.52 | 1.87 | 1.93 |

##### Income Statement (Three Months Ended September 30,)

| | Three Months Ended September 30, – 2026 | Three Months Ended September 30, – 2025 | Twelve Months Ended September 30, – 2026 | Twelve Months Ended September 30, – 2025 |
|---|---:|---:|---:|---:|
| Diluted earnings (loss) per share as reported | -0.62 | 0.22 | -0.22 | -3.39 |
| EBIT adjustments total | 1.33 | 0.27 | 2.4 | 5.47 |
| Tax impact of EBIT adjustments and other tax items | -0.16 | -0.05 | -0.24 | -0.18 |
| Pension mark-to-market & settlement loss | -0.22 | 0.09 | -0.19 | 0.08 |
| Fees paid on Term Loan B modifications | 0.03 |  | 0.03 |  |
| Premium paid on repurchase of debt | 0.13 |  | 0.13 |  |
| Write off of deferred financing costs upon repurchase of debt | 0.04 |  | 0.04 | 0.02 |
| Impact of adjustments on noncontrolling interests | -0.01 | -0.01 | -0.08 | -0.07 |
| Adjusted diluted earnings per share | 0.52 | 0.52 | 1.87 | 1.93 |

##### Balance Sheet (September 30, — (Unaudited) (in millions))

| | September 30, – 2026 | September 30, – 2025 |
|---|---:|---:|
| Cash and cash equivalents | 886 | 958 |
| Accounts receivable - net | 1,975 | 1,873 |
| Inventories | 690 | 695 |
| Other current assets | 495 | 607 |
| Current assets | 4,046 | 4,133 |
| Property, plant and equipment - net | 1,401 | 1,409 |
| Goodwill | 1,808 | 1,807 |
| Other intangible assets - net | 290 | 319 |
| Investments in partially-owned affiliates | 267 | 276 |
| Assets held for sale | 20 | 9 |
| Other noncurrent assets | 986 | 1,001 |
| Total assets | 8,818 | 8,954 |
| **Liabilities and Shareholders' Equity** | | |
| Short-term debt | 14 | 11 |
| Accounts payable and accrued expenses | 3,058 | 2,942 |
| Other current liabilities | 656 | 734 |
| Current liabilities | 3,728 | 3,687 |
| Long-term debt | 2,338 | 2,386 |
| Other noncurrent liabilities | 737 | 723 |
| Redeemable noncontrolling interests | 88 | 95 |
| Shareholders' equity attributable to Adient | 1,634 | 1,766 |
| Noncontrolling interests | 293 | 297 |
| Total liabilities and shareholders' equity | 8,818 | 8,954 |
